Marco Loffi

1.3k total citations
24 papers, 699 citations indexed

About

Marco Loffi is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases and Surgery. According to data from OpenAlex, Marco Loffi has authored 24 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 9 papers in Infectious Diseases and 7 papers in Surgery. Recurrent topics in Marco Loffi's work include COVID-19 Clinical Research Studies (7 papers), Cardiac Imaging and Diagnostics (6 papers) and Coronary Interventions and Diagnostics (6 papers). Marco Loffi is often cited by papers focused on COVID-19 Clinical Research Studies (7 papers), Cardiac Imaging and Diagnostics (6 papers) and Coronary Interventions and Diagnostics (6 papers). Marco Loffi collaborates with scholars based in Italy, United States and Canada. Marco Loffi's co-authors include Gian Battista Danzi, Gianluca Galeazzi, Elisa Gherbesi, Giuseppe Di Tano, Maurizio Tespili, Alfonso Ielasi, Giuseppe De Blasio, Alberto Margonato, Andrea Salonia and Raffaele Piccolo and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Heart Journal and BioMed Research International.

In The Last Decade

Marco Loffi

22 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Loffi Italy 12 467 251 160 147 133 24 699
Shari B. Brosnahan United States 12 533 1.1× 257 1.0× 236 1.5× 132 0.9× 437 3.3× 32 917
Rafael Harari United States 6 461 1.0× 262 1.0× 176 1.1× 232 1.6× 37 0.3× 14 654
Francesco Poletto Italy 6 483 1.0× 245 1.0× 146 0.9× 31 0.2× 144 1.1× 10 610
Bindu Akkanti United States 14 365 0.8× 197 0.8× 117 0.7× 117 0.8× 19 0.1× 80 898
Raphaël Le Mao France 12 210 0.4× 109 0.4× 105 0.7× 154 1.0× 338 2.5× 47 556
Mara Falco Italy 5 586 1.3× 335 1.3× 271 1.7× 31 0.2× 184 1.4× 7 823
Fahad Faqihi Saudi Arabia 15 349 0.7× 293 1.2× 77 0.5× 28 0.2× 34 0.3× 35 660
Stefano Pelenghi Italy 9 561 1.2× 311 1.2× 109 0.7× 362 2.5× 13 0.1× 33 841
Marco Resta Italy 6 601 1.3× 319 1.3× 210 1.3× 29 0.2× 181 1.4× 12 782
Januar Wibawa Martha Indonesia 10 255 0.5× 129 0.5× 62 0.4× 108 0.7× 18 0.1× 37 434

Countries citing papers authored by Marco Loffi

Since Specialization
Citations

This map shows the geographic impact of Marco Loffi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Loffi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Loffi more than expected).

Fields of papers citing papers by Marco Loffi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Loffi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Loffi. The network helps show where Marco Loffi may publish in the future.

Co-authorship network of co-authors of Marco Loffi

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Loffi. A scholar is included among the top collaborators of Marco Loffi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Loffi. Marco Loffi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Darroudi, Susan, Marco Loffi, Valentina Selleri, et al.. (2025). Adherence to Exercise and Functional Rehabilitation Programs in Patients with Cardiovascular Diseases: Barriers and Strategies. Journal of Cardiovascular Development and Disease. 13(1). 8–8.
2.
Lupi, Laura, Alessandro Villaschi, Beniamino Pagliaro, et al.. (2025). Aetiological Phenotypes of Atrial and Ventricular Secondary Tricuspid Regurgitation and Their Prognostic Implications: Insights from the CARE-TR Registry. European Journal of Heart Failure. 27(8). 1549–1558.
3.
Pellegrini, Dario, Michael Donahue, Damiano Regazzoli, et al.. (2023). Drug-coated balloon combined with drug-eluting stent for the treatment of coronary bifurcation lesions: insights from the HYPER study. European Heart Journal Supplements. 25(Supplement_C). C79–C83. 12 indexed citations
4.
Buono, Andrea, Mariano Pellicano, Damiano Regazzoli, et al.. (2023). Procedural and one-year outcomes following drug-eluting stent and drug-coated balloon combination for the treatment of de novo diffuse coronary artery disease: the HYPER Study. Minerva Cardiology and Angiology. 72(2). 163–171. 6 indexed citations
5.
Giuli, Valeria De, et al.. (2021). A masked ST-elevation myocardial infarction. Journal of Clinical Images and Medical Case Reports. 2(4). 2 indexed citations
6.
Cereda, Alberto, Marco Toselli, Anna Palmisano, et al.. (2021). Coronary calcium score as a predictor of outcomes in the hypertensive Covid-19 population: results from the Italian (S) Core-Covid-19 Registry. Hypertension Research. 45(2). 333–343. 17 indexed citations
7.
Tano, Giuseppe Di, et al.. (2020). Le ricadute della pandemia COVID-19 sulla gestione dell’Ambulatorio Scompenso. Esperienze e considerazioni operative dopo il lockdown. Giornale italiano di cardiologia. 21(10). 750–756. 3 indexed citations
8.
Ielasi, Alfonso, Andrea Buono, Mariano Pellicano, et al.. (2020). A HYbrid APproach Evaluating a DRug-Coated Balloon in Combination With a New-Generation Drug-Eluting Stent in the Treatment of De Novo Diffuse Coronary Artery Disease: The HYPER Pilot Study. Cardiovascular revascularization medicine. 28. 14–19. 19 indexed citations
9.
Loffi, Marco, et al.. (2020). Spontaneous pneumomediastinum in COVID-19 pneumonia. SHILAP Revista de lepidopterología. 90(4). 17 indexed citations
10.
Loffi, Marco, et al.. (2020). Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection. Heart and Vessels. 36(1). 115–120. 10 indexed citations
11.
Loffi, Marco, et al.. (2020). Glucocorticoid-Induced Bacterial Endocarditis in COVID-19 Pneumonia ― Something to Be Concerned About? ―. Circulation Journal. 84(10). 1887–1887. 9 indexed citations
12.
Tano, Giuseppe Di, et al.. (2020). Late Pulmonary Embolism after COVID-19 Pneumonia despite Adequate Rivaroxaban Treatment. SHILAP Revista de lepidopterología. 7(7). 15 indexed citations
13.
Galeazzi, Gianluca, Marco Loffi, Giuseppe Di Tano, & Gian Battista Danzi. (2020). Severe COVID-19 Pneumonia and Very Late Stent Thrombosis: a Trigger or Innocent Bystander?. Korean Circulation Journal. 50(7). 632–632. 10 indexed citations
14.
Danzi, Gian Battista, Marco Loffi, Gianluca Galeazzi, & Elisa Gherbesi. (2020). Acute pulmonary embolism and COVID-19 pneumonia: a random association?. European Heart Journal. 41(19). 1858–1858. 457 indexed citations
15.
Ielasi, Alfonso, Marco Loffi, Giuseppe De Blasio, & Maurizio Tespili. (2019). “Rota-Tripsy”: A Successful Combined Approach for the Treatment of a Long and Heavily Calcified Coronary Lesion. Cardiovascular revascularization medicine. 21(11). 152–154. 18 indexed citations
16.
Loffi, Marco, Petr Toušek, Libor Lisa, et al.. (2018). Optical coherence tomography in STEMI with bioresorbable scaffold: possible cause of coronary flow impairment? A sub-study from the Prague 19 trial. Heart and Vessels. 33(11). 1282–1287. 1 indexed citations
17.
Loffi, Marco, et al.. (2015). Self‐Terminating Ventricular Fibrillation in Vandetanib‐Induced Torsades de Pointes. Journal of Cardiovascular Electrophysiology. 26(7). 811–813. 2 indexed citations
18.
Gorla, Riccardo, Marco Loffi, Edoardo Verna, Alberto Margonato, & Jorge A. Salerno‐Uriarte. (2014). Safety and efficacy of first-generation and second-generation drug-eluting stents in the setting of acute coronary syndromes. Journal of Cardiovascular Medicine. 15(7). 532–542. 1 indexed citations
19.
Rossi, Andrea, Nicola Gaibazzi, Eustachio Agricola, et al.. (2014). Aortic valve sclerosis as a marker of coronary artery atherosclerosis; a multicenter study of a large population with a low prevalence of coronary artery disease. International Journal of Cardiology. 172(2). 364–367. 22 indexed citations
20.
Torlasco, Camilla, Marco Loffi, Francesco Maranta, et al.. (2013). Erectile dysfunction in heart failure patients: a critical reappraisal. Andrology. 1(2). 177–191. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026